131 related articles for article (PubMed ID: 12814142)
1. Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.
Sans-Torres J; Domingo C; Morón A; Rué M; Marín A
Respir Med; 2003 Jun; 97(6):599-605. PubMed ID: 12814142
[TBL] [Abstract][Full Text] [Related]
2. Effects of almitrine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia: a multicentre, randomised, double-blind, placebo-controlled study.
Górecka D; Sliwiński P; Pałasiewicz G; Pachocki R; Zieliński J;
Respiration; 2003; 70(3):275-83. PubMed ID: 12915747
[TBL] [Abstract][Full Text] [Related]
3. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
Winkelmann BR; Kullmer TH; Kneissl DG; Trenk D; Kronenberger H
Chest; 1994 May; 105(5):1383-91. PubMed ID: 8181324
[TBL] [Abstract][Full Text] [Related]
4. [Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages].
Nowak D; Wywiol A; Magnussen H
Pneumologie; 1998 Mar; 52(3):121-7. PubMed ID: 9564184
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
Gothe B; Cherniack NS; Bachand RT; Szalkowski MB; Bianco KA
Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
[TBL] [Abstract][Full Text] [Related]
6. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
Weitzenblum E; Schrijen F; Apprill M; Prefaut C; Yernault JC
Eur Respir J; 1991 Nov; 4(10):1215-22. PubMed ID: 1804669
[TBL] [Abstract][Full Text] [Related]
7. [Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
Wuttke R; von Wichert P
Respiration; 1985; 48(4):285-95. PubMed ID: 3936140
[TBL] [Abstract][Full Text] [Related]
8. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
Bardsley PA; Howard P; Tang O; Empey D; Harrison B; Peake MD; O'Reilly J; Riordan JF; Wilkinson J; Arnaud F
Eur Respir J; 1992 Oct; 5(9):1054-61. PubMed ID: 1426214
[TBL] [Abstract][Full Text] [Related]
9. Almitrine effect on nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease (COPD).
Daskalopoulou E; Patakas D; Tsara V; Kazis A; Maniki E; Zoglopitis F
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():185s-190s. PubMed ID: 3690030
[TBL] [Abstract][Full Text] [Related]
10. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
[TBL] [Abstract][Full Text] [Related]
11. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
Bardsley PA; Howard P; DeBacker W; Vermeire P; Mairesse M; Ledent C; Radermecker M; Bury T; Ansquer J
Eur Respir J; 1991 Mar; 4(3):308-10. PubMed ID: 1907566
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
[TBL] [Abstract][Full Text] [Related]
13. Long term studies on almitrine bismesylate in COPD patients.
Bourgouin-Karaouni D; Mercier J; Prefaut C
Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
[TBL] [Abstract][Full Text] [Related]
14. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease.
Bardsley PA; Tweney J; Morgan N; Howard P
Thorax; 1991 Jul; 46(7):493-8. PubMed ID: 1908604
[TBL] [Abstract][Full Text] [Related]
15. Almitrine fails to improve oxygenation during one-lung ventilation with sevoflurane anesthesia.
Bermejo S; Gallart L; Silva-Costa-Gomes T; Vallès J; Aguiló R; Puig MM
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):919-24. PubMed ID: 24016684
[TBL] [Abstract][Full Text] [Related]
16. High or low doses of almitrine bismesylate in ARDS patients responding to inhaled NO and receiving norepinephrine?
Roch A; Papazian L; Bregeon F; Gainnier M; Michelet P; Thirion X; Saux P; Thomas P; Jammes Y; Auffray JP
Intensive Care Med; 2001 Nov; 27(11):1737-43. PubMed ID: 11810116
[TBL] [Abstract][Full Text] [Related]
17. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease.
Daskalopoulou E; Patakas D; Tsara V; Zoglopitis F; Maniki E
Thorax; 1990 Sep; 45(9):666-9. PubMed ID: 2145654
[TBL] [Abstract][Full Text] [Related]
18. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Voisin C; Howard P; Ansquer JC
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
[TBL] [Abstract][Full Text] [Related]
19. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
Bury T; Jeannot JP; Ansquer JC; Radermecker M
Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
Watanabe S; Kanner RE; Cutillo AG; Menlove RL; Bachand RT; Szalkowski MB; Renzetti AD
Am Rev Respir Dis; 1989 Nov; 140(5):1269-73. PubMed ID: 2683905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
